Literature DB >> 19307365

Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital.

Kevin S Akers1, Katrin Mende, Heather C Yun, Duane R Hospenthal, Miriam L Beckius, Xin Yu, Clinton K Murray.   

Abstract

Infections with multidrug-resistant Acinetobacter baumannii-Acinetobacter calcoaceticus complex bacteria complicate the care of U.S. military personnel and civilians worldwide. One hundred thirty-three isolates from 89 patients at our facility during 2006 and 2007 were tested by disk diffusion, Etest, and broth microdilution for susceptibility to tetracycline, doxycycline, minocycline, and tigecycline. Minocycline was the most active in vitro, with 90% of the isolates tested susceptible. Susceptibilities varied significantly with the testing method. The acquired tetracycline resistance genes tetA, tetB, and tetA(39) were present in the isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307365      PMCID: PMC2687211          DOI: 10.1128/AAC.01405-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.

Authors:  Paul Scott; Gregory Deye; Arjun Srinivasan; Clinton Murray; Kimberly Moran; Ed Hulten; Joel Fishbain; David Craft; Scott Riddell; Luther Lindler; James Mancuso; Eric Milstrey; Christian T Bautista; Jean Patel; Alessa Ewell; Tacita Hamilton; Charla Gaddy; Martin Tenney; George Christopher; Kyle Petersen; Timothy Endy; Bruno Petruccelli
Journal:  Clin Infect Dis       Date:  2007-05-08       Impact factor: 9.079

2.  Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species.

Authors:  Jane F Turton; Neil Woodford; Judith Glover; Susannah Yarde; Mary E Kaufmann; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.

Authors:  Joshua S Hawley; Clinton K Murray; Matthew E Griffith; M Leticia McElmeel; Letitia C Fulcher; Duane R Hospenthal; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

4.  Novel tetracycline resistance determinant isolated from an environmental strain of Serratia marcescens.

Authors:  Stuart A Thompson; Elizabeth V Maani; Angela H Lindell; Catherine J King; J Vaun McArthur
Journal:  Appl Environ Microbiol       Date:  2007-02-16       Impact factor: 4.792

5.  Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.

Authors:  Jana M Swenson; George E Killgore; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Diversity of tetracycline resistance genes in bacteria from Chilean salmon farms.

Authors:  Claudio D Miranda; Corinna Kehrenberg; Catherine Ulep; Stefan Schwarz; Marilyn C Roberts
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

7.  The tetracycline resistance determinant Tet 39 and the sulphonamide resistance gene sulII are common among resistant Acinetobacter spp. isolated from integrated fish farms in Thailand.

Authors:  Yvonne Agersø; Andreas Petersen
Journal:  J Antimicrob Chemother       Date:  2006-11-09       Impact factor: 5.790

8.  Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

Authors:  Ronald N Jones; Mary Jane Ferraro; L Barth Reller; Paul C Schreckenberger; Jana M Swenson; Helio S Sader
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

9.  Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis.

Authors:  M Vaneechoutte; L Dijkshoorn; I Tjernberg; A Elaichouni; P de Vos; G Claeys; G Verschraegen
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

  9 in total
  17 in total

1.  In vitro characterization of multivalent adhesion molecule 7-based inhibition of multidrug-resistant bacteria isolated from wounded military personnel.

Authors:  Anne Marie Krachler; Katrin Mende; Clinton Murray; Kim Orth
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

2.  Simultaneous Identification of Multiple β-Lactamases in Acinetobacter baumannii in Relation to Carbapenem and Ceftazidime Resistance, Using Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Hein Trip; Katrin Mende; Joanna A Majchrzykiewicz-Koehorst; Norbert J A Sedee; Albert G Hulst; Hugo-Jan Jansen; Clinton K Murray; Armand Paauw
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

Review 3.  Efflux-mediated antibiotic resistance in Acinetobacter spp.

Authors:  Sébastien Coyne; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

4.  Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration.

Authors:  Kevin S Akers; Jason M Cota; Christopher R Frei; Kevin K Chung; Katrin Mende; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

5.  Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities.

Authors:  Galarah D Golanbar; Christopher K Lam; Yi-Ming Chu; Carla Cueva; Stephanie W Tan; Isba Silva; H Howard Xu
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

Review 6.  Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat.

Authors:  David A Butler; Mark Biagi; Xing Tan; Samah Qasmieh; Zackery P Bulman; Eric Wenzler
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

7.  Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.

Authors:  C Rumbo; E Gato; M López; C Ruiz de Alegría; F Fernández-Cuenca; L Martínez-Martínez; J Vila; J Pachón; J M Cisneros; J Rodríguez-Baño; A Pascual; G Bou; M Tomás
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

8.  Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities.

Authors:  Chris Rowe Taitt; Tomasz A Leski; Michael G Stockelman; David W Craft; Daniel V Zurawski; Benjamin C Kirkup; Gary J Vora
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

9.  Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex.

Authors:  Kevin S Akers; Chris Chaney; Alice Barsoumian; Miriam Beckius; Wendy Zera; Xin Yu; Charles Guymon; Edward F Keen; Brian J Robinson; Katrin Mende; Clinton K Murray
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

10.  Biofilm formation by clinical isolates and the implications in chronic infections.

Authors:  Carlos J Sanchez; Katrin Mende; Miriam L Beckius; Kevin S Akers; Desiree R Romano; Joseph C Wenke; Clinton K Murray
Journal:  BMC Infect Dis       Date:  2013-01-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.